Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction
- Conditions
- Acute Myocardial Infarction
- Interventions
- Drug: PlaceboDrug: NL005 High DoseDrug: NL005 Middle Dose
- First Posted Date
- 2023-08-09
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Target Recruit Count
- 90
- Registration Number
- NCT05984134
- Locations
- 🇨🇳
Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China
Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT05968118
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction
- Conditions
- Acute Myocardial Infarction
- Interventions
- Drug: Low DoseDrug: Middle DoseDrug: High DoseOther: Placebo
- First Posted Date
- 2022-08-03
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Target Recruit Count
- 62
- Registration Number
- NCT05485818
- Locations
- 🇨🇳
Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China
A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2020-09-29
- Lead Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT04555824
- Locations
- 🇨🇳
Beijing Shijitan Hospital, Beijing, China
A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2020-09-29
- Lead Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT04555850
- Locations
- 🇨🇳
Beijing Shijitan Hospital, Beijing, China
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)
- Conditions
- IschemiaPeripheral Vascular DiseaseUlcersArterial Occlusive Disease
- Interventions
- Genetic: NL003Other: Normal Saline
- First Posted Date
- 2020-02-19
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT04275323
- Locations
- 🇨🇳
Beijing Hospitai, Beijing, Beijing, China
🇨🇳Peking Union Medical College Hospital, Beijing, Beijing, China
🇨🇳The Ninth People's Hospital of Chongqing, Chongqing, Chongqing, China
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)
- Conditions
- Peripheral Vascular DiseaseIschemiaArterial Occlusive DiseaseUlcers
- Interventions
- Other: Normal SalineGenetic: NL003
- First Posted Date
- 2020-02-18
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Target Recruit Count
- 242
- Registration Number
- NCT04274049
- Locations
- 🇨🇳
Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
🇨🇳Zhongshan Hospital Xiamen University, Xiamen, Fujian, China
🇨🇳The First Affiliated Hospital of Zhengzhou University, Chang chun, Jilin, China
A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11
- Conditions
- Chemotherapy-induced Thrombocytopenia
- Interventions
- First Posted Date
- 2012-08-13
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Target Recruit Count
- 62
- Registration Number
- NCT01663441
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
🇨🇳The Third Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
🇨🇳Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
- Conditions
- UlcersArterial Occlusive DiseaseIschemiaPeripheral Vascular Disease
- Interventions
- Genetic: NL003Other: Normal Saline
- First Posted Date
- 2012-03-08
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT01548378
- Locations
- 🇨🇳
Beijing Shijitan Hospital, Beijing, Beijing, China
🇨🇳First Hospital of Jilin University, Changchun, Jilin, China
🇨🇳The Second Hospital of Dalian Medical University, Dalian, Liaoning, China